Construction work on Amiens Anti-Covid Vaccine Manufacturing Plant located in Amiens, Hauts-de-France, France commenced in Q2 2023, after the project was announced in Q4 2021. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2027. To learn more about the Amiens Anti-Covid Vaccine Manufacturing Plant project, buy the profile here.
The project involves the construction of a 6,000m2 Anti-Covid-19 vaccine plant at the Amiens plant, Somme department, Hauts-de-France region, France.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of a manufacturing facility
2. Construction of a laboratory
3. Construction of testing units
4. Construction of storage facilities
5. Construction of an administrative facility
6. Construction of distribution units
7. Construction of five filling lines
8. Installation of machinery and related facilities
Construction on the project is expected to be completed by Q4 2027.
France-based Unither Pharmaceuticals is the architect and engineering design consultant for the Amiens Anti-Covid Vaccine Manufacturing Plant, while Amiens Metropole is the planning authority.
For more details on the Amiens Anti-Covid Vaccine Manufacturing Plant project, buy the profile here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying research used to produce this article.
GlobalData’s Construction Projects database tracks over 220,000 new construction projects valued at >$25m from announcement to completion across all countries and sectors.
